Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

tinzaparin

tinzaparin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Innohep SOLUTION, SUBCUTANEOUS 20,000 units/mL    
Comments:
ORDERED FORMULATION THERAPEUTIC INTERCHANGE

NOTES
  • tinzaparin (Innohep) 175 units/kg every 24hrs     
  •  enoxaparin 1mg/kg subcutaneously q 12 hrs, for treatment of DVT with or without pulmonary embolism

tinzaparin is not currently marketed in the US.  Round to nearest 10 mg.

Pharmacists (through PKS) may automatically order Anti-Xa levels on patients where LMWH dosing may be problematic (i.e., renal compromise, obesity, pregnancy, etc.), with follow-up physician communication.

Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved